Research Supervisor Connect
This project offers PhD and postdoctoral researchers the opportunity to contribute to the development and stabilisation of next-generation biologics and vaccines for cancer, autoimmune, and infectious diseases, within a well-established research program and in collaboration with industry.
Associate Professor Veysel Kayser.
PHD
We are expanding a well-established, multidisciplinary research program focused on the development and stabilisation of next-generation biologics, including monoclonal antibodies (mAbs), antibody–drug conjugates (ADCs), bispecifics, and nanomedicine platforms, for applications in cancer, autoimmune, and infectious diseases. Some aspects of this work are conducted in collaboration with a major pharmaceutical company and are based at the Sydney Pharmacy School.
Key research areas include:
· Developing novel mAb-based drug candidates and vaccines
· Understanding and predicting protein aggregation and degradation
· Developing novel formulation strategies and analytical tools
· Applying advanced biophysical characterisation techniques such as fluorescence spectroscopy, transmission electron microscopy (TEM), and dynamic light scattering (DLS)
· Integrating computational modelling and machine learning to support formulation design and mechanistic understanding
We invite expressions of interest from highly motivated PhD and postdoctoral researchers with backgrounds in pharmacy, chemistry, chemical engineering, biotechnology, or related fields. Successful candidates will join a dynamic and collaborative environment with strong industry links and opportunities for high-impact translational research.
A/Prof Veysel Kayser leads a well-established research program in biotherapeutics and vaccine development, with five current PhD students and nine completions. His work has been recognised with NSW Health awards and a gold medal at the 49th Geneva International Exhibition of Inventions. He collaborates internationally, consults for organisations including the WHO and TGA, and serves on editorial boards of peer-reviewed journals.
The opportunity ID for this research opportunity is 1891